EPIX: ESSA Pharma Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 76.79
Enterprise Value ($M) -26.92
Book Value ($M) 124.61
Book Value / Share 2.81
Price / Book 0.62
NCAV ($M) 124.05
NCAV / Share 2.79
Price / NCAV 0.62

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.20

Liquidity (mrq)
Quick Ratio 38.64
Current Ratio 38.64

Balance Sheet (mrq) ($M)
Current Assets 127.56
Assets 128.11
Liabilities 3.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -34.42
Net Income -28.54

Cash Flow Statement (mra) ($M)
Cash From Operations -22.72
Cash from Investing 91.79
Cash from Financing 0.93

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Rtw Investments, Lp 7.40 41.89
11-14 13G/A Bb Biotech Ag 0.00 -100.00
11-14 13G/A PFM Health Sciences, LP 6.20
11-08 13D Tang Capital Management Llc 9.70
11-07 13G BML Investment Partners, L.P. 9.40
02-08 13G Morgan Stanley 9.50
2024-01-23 13G/A Soleus Capital, LLC 9.80 11.84

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 24,682 247,881 9.96
2025-01-30 39,982 146,984 27.20
2025-01-29 11,775 177,672 6.63
2025-01-28 10,265 97,217 10.56

(click for more detail)

Similar Companies
ENTO – Entero Therapeutics, Inc. ENTX – Entera Bio Ltd.
ENVB – Enveric Biosciences, Inc. EQ – Equillium, Inc.
ERNA – Eterna Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io